GoodRx Announces Launch of Direct Contracting for Independent Pharmacies in June 2025

Reuters
22 May
GoodRx Announces Launch of Direct Contracting for Independent Pharmacies in June 2025

GoodRx Holdings Inc., a prominent platform for medication savings in the U.S., has announced the upcoming launch of GoodRx Community Link, a new offering designed for independent community pharmacies. Set to roll out in June 2025, this initiative will allow locally owned pharmacies to engage in direct contracting with GoodRx on pricing matters, thereby offering them greater control and more favorable margins through cost-plus models. This move aims to empower independent pharmacies in managing their pricing strategies while ensuring consumers continue to benefit from affordable medication prices. To provide more details on this initiative, GoodRx will host a webinar featuring Aaron Crittenden, President of Rx Marketplace at GoodRx, on June 3 and 4. Interested parties can register for the event on the GoodRx website.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. GoodRx Holdings Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 20250522881687) on May 22, 2025, and is solely responsible for the information contained therein.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10